Kinnos — a startup reimagining the way hospitals disinfect their surfaces by colorizing the process — recently raised $15 million in financing. Through better sanitization practices, the company is seeking to decrease hospital-acquired infections, which cause 72,000 deaths every year.
The Centers for Medicare & Medicaid Services identified 786 hospitals that will receive lower payments for a year under the Hospital-Acquired Conditions Reduction Program and it included seven of the 21 hospitals on the U.S. News Best Hospitals Honor Roll.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Seventy-one percent of reusable medical scopes deemed ready for use on patients tested positive for bacteria at three major U.S. hospitals, according to a new study published in the American Journal of Infection Control.
CMS is cracking down on hospital-acquired infections, starting with MRSA and C. difficile.
At least 79 cases of infection tied to Sorin heater-cooler units in the U.S. and worldwide have been reported to the FDA since 2010, including 12 deaths. Those numbers are expected to rise.
San Antonio-based Xenex Disinfection Services produces the germ-zapping robots, which emanate pulsed UV light in high doses.
According to the inspectors’ report, the head of infection control at the hospital not only neglected to monitor the compounding lab, but also falsified documents to cover up her failure to check practices in the operating rooms in 2015.
The DEVICE Act would impose new requirements on manufacturers. The companies would have to notify the FDA when they issue safety warnings in other countries related to the design and cleaning of their devices.
The newly formed Electronic Hand Hygiene Compliance Organization, or EHCO, plans on lobbying CMS, private payers, the Joint Commission and patient safety organizations.
Also, an early stage clinical trial of a pain medication has led to hospitalizations and one death.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
"That rate is still too high," AHRQ said in its report, even though a press release from HHS tried to paint a rosier picture.
This week, Consumer Reports called out "12 hospitals you might want to avoid," and named names.
If transmitting superbugs with scopes such a problem, why do we use the reusable devices?
SwipeSense graduated from Healthbox, which has invested in the business along with Jumpstart.
Atlas Genetics, a British molecular diagnostics startup that creates rapid point-of-care tests for infectious diseases like chlamydia, will launch U.S. clinical trials with a $20 million Series C round. It will also expand its test offerings in the sexually transmitted infection and hospital acquired infection markets, Atlas said in a release. The company’s io(R) molecular diagnostic cartridge contains all the […]
